The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

In the June 2014 issue of JAMA Internal Medicine, study authors Wen-Qing Li, PhD; Abrar A. Qureshi, MD, MPH; Kathleen C. Robinson, PhD; and Jiali Han, PhD delved into that very subject through the undertaking of a prospective cohort study involving 25,848 US males. Participants who reported cancers at baseline were excluded from the study, which commenced in 2000 and encompassed a 10-year window for follow-up.

In the end, the study authors identified 142 cases of melanoma, 580 cases of Squamous Cell Carcinoma (SCC) and no fewer than 3,030 cases of Basal Cell Carcinoma (BCC). In the end, the study authors ruled out SCC and BCC as they did not observe an increased risk related to sildenafil. However, melanoma was another story. “Recent sildenafil use at baseline was significantly associated with an increased risk of subsequent melanoma with a multivariate-adjusted hazard ratio (HR) of 1.84 (95% CI, 1.04-3.22),” the researchers said.

The study authors concluded, “Sildenafil [Viagra] use may be associated with an increased risk of developing melanoma. Although this study is insufficient to alter clinical recommendations, we support a need for continued investigation of this association.”
If you or a loved one has taken Viagra and suffered from Melanoma please contact Jamie Sheller Esq. at 1800 883 2299

Comments are closed.

Of Interest